CLINICAL_TRIALS
trial_result
· 2016-08-17
Clinical Trial Update: A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients. [Phase 3]
Summary
Phase 3 trial evaluating subcutaneous Mircera for anemia in peritoneal dialysis patients was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: TERMINATED | Results posted: 2016-08-17